OTCMKTS:EXDI - Exactus Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$1.75 0.00 (0.00 %)
(As of 03/21/2019 04:00 PM ET)
Previous Close$1.75
Today's Range$1.30 - $1.85
52-Week Range$0.0060 - $0.30
Volume11,628 shs
Average Volume217,289 shs
Market Capitalization$69.61 million
P/E RatioN/A
Dividend YieldN/A
Exactus, Inc., a life science company, focuses on developing and commercializing point-of-care diagnostics for measuring proteolytic enzymes in the blood. The company is developing FibriLyzer device to address the shortcomings of the viscoelastometric devices and clinical tests, such as D-dimer, as well as euglobulin lysis test; and MatriLyzer, a diagnostic device to detect the recurrence of cancer. The company is based in Glen Allen, Virginia. As of January 8, 2019, Exactus, Inc. operates as a subsidiary of Ceed2Med, LLC.

Receive EXDI News and Ratings via Email

Sign-up to receive the latest news and ratings for EXDI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Heating equipment, except electric
Current SymbolOTCMKTS:EXDI



Sales & Book Value

Annual SalesN/A
Book Value($0.06) per share


Net Income$-3,860,000.00


Market Cap$69.61 million
Next Earnings Date4/1/2019 (Estimated)
OptionableNot Optionable

Exactus (OTCMKTS:EXDI) Frequently Asked Questions

What is Exactus' stock symbol?

Exactus trades on the OTCMKTS under the ticker symbol "EXDI."

When is Exactus' next earnings date?

Exactus is scheduled to release their next quarterly earnings announcement on Monday, April 1st 2019. View Earnings Estimates for Exactus.

Has Exactus been receiving favorable news coverage?

News headlines about EXDI stock have trended neutral this week, InfoTrie reports. The research group identifies positive and negative news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Exactus earned a coverage optimism score of 0.5 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 7.0 out of 10, meaning that recent news coverage is likely to have an effect on the stock's share price in the immediate future.

Who are some of Exactus' key competitors?

What other stocks do shareholders of Exactus own?

Who are Exactus' key executives?

Exactus' management team includes the folowing people:
  • Mr. Philip J. Young, Chairman, Pres & CEO (Age 62)
  • Ms. Kelley A. Wendt, CFO & Treasurer (Age 45)
  • Mr. Timothy Ryan, Exec. VP & Director (Age 58)
  • Dr. James R. Erickson Ph.D., Chief Bus. Officer (Age 56)
  • Mr. Jonathan R. Gilbert, Exec. Chairman (Age 48)

How do I buy shares of Exactus?

Shares of EXDI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Exactus' stock price today?

One share of EXDI stock can currently be purchased for approximately $1.75.

How big of a company is Exactus?

Exactus has a market capitalization of $69.61 million.

What is Exactus' official website?

The official website for Exactus is http://www.exactusinc.com.

How can I contact Exactus?

Exactus' mailing address is 4870 SADLER RD. SUITE 300, GLEN ALLEN VA, 23060. The company can be reached via phone at 804-205-5036.

MarketBeat Community Rating for Exactus (OTCMKTS EXDI)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  16 (Vote Outperform)
Underperform Votes:  14 (Vote Underperform)
Total Votes:  30
MarketBeat's community ratings are surveys of what our community members think about Exactus and other stocks. Vote "Outperform" if you believe EXDI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EXDI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/21/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel